APA

Liebowitz D., Gottlieb K., Kolhatkar N. S., Garg S. J., Asher J. M., Nazareno J., Kim K., McIlwain D. R. & Tucker S. N. (20200806). Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study. : The Lancet. Infectious diseases.

Chicago

Liebowitz David, Gottlieb Keith, Kolhatkar Nikita S, Garg Shaily J, Asher Jason M, Nazareno Jonathan, Kim Kenneth, McIlwain David R and Tucker Sean N. 20200806. Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study. : The Lancet. Infectious diseases.

Harvard

Liebowitz D., Gottlieb K., Kolhatkar N. S., Garg S. J., Asher J. M., Nazareno J., Kim K., McIlwain D. R. and Tucker S. N. (20200806). Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study. : The Lancet. Infectious diseases.

MLA

Liebowitz David, Gottlieb Keith, Kolhatkar Nikita S, Garg Shaily J, Asher Jason M, Nazareno Jonathan, Kim Kenneth, McIlwain David R and Tucker Sean N. Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study. : The Lancet. Infectious diseases. 20200806.